Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MEG-guided rTMS for Migraine
NCT06796725Recruiting
- Sponsor
- Ruijin Hospital
- Start
- Feb 2025
- Primary completion
- Jun 2026
- Countries
- 1
01
Overview
Randomised, single-blind trial (2 arms), sponsored by Ruijin Hospital. Primary endpoint: Headache Scale Reduction Rate at 4 weeks. Started Feb 2025; status: recruiting.
Beyond the preview
Go deeper on NCT06796725.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06796725.